Evidence map›Paper›PMID 40164717›Full record

ArticleLeukemia2025

Zanubrutinib in Bing Neel syndrome: efficacy and tolerability.

Anne-Marie L Becking, Johannes P M van de Mortel, Oliver Tomkins, Thijs W H Flinsenberg, Nicole Japzon, Marie José Kersten, Jahanzaib Khwaja, Saskia Kuipers, Henriette Levenga, Sean McKeague and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Anne-Marie L Becking *Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.l.becking@amsterdamumc.nl.ORCID http://orcid.org/0009-0004-2942-9385
Johannes P M van de Mortel *Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-9956-744X
Oliver TomkinsDepartment of Haematology, Center for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-1059-2906
Thijs W H FlinsenbergDepartment of Hematology, Rijnstate Hospital, Arnhem, The Netherlands.
Nicole JapzonDepartment of Haematology, Center for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK.
Marie José KerstenDepartment of Hematology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8904-3802
Jahanzaib KhwajaDepartment of Haematology, Center for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-4993-7828
Saskia KuipersDepartment of Hematology, Admiraal de Ruyter Hospital, Goes, The Netherlands.
Henriette LevengaDepartment of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands.
Sean McKeagueDepartment of Hematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Stephen OpatDepartment of Hematology, Monash Health, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0002-0308-6458
Ross T SalvarisDepartment of Hematology, Monash Health, Monash University, Clayton, VIC, Australia.
Sherif SeifDepartment of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Sheeba K ThomasDepartment of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Alexander F J E VranckenDepartment of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4649-6534
Shirley D'SaDepartment of Haematology, Center for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0003-0840-3499
Monique C MinnemaDepartment of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-3139-8379
Josephine M I VosDepartment of Hematology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3229-9556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40164717
PMCPMC12055574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.